Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer
Nadine Bley, Alexander Rausch, Simon Müller, Theresa Simon, Markus Glaß, Danny Misiak, Laura Schian, Lara Meret Peters, Mohammad Dipto, Ali Hmedat, Bianca Busch, Annekatrin Schott, Marcell Lederer, Alice Wedler, Robin Benedikt Rolnik, Hend Elrewany, Ehab Ghazy, Wolfgang Sippl, Martina Vetter, Markus · 2025
Read Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer by Nadine Bley, Alexander Rausch, Simon Müller, Theresa Simon, Markus Glaß, Danny Misiak, Laura Schian, Lara Meret Peters, Mohammad Dipto, Ali Hmedat, Bianca Busch, Annekatrin Schott, Marcell Lederer, Alice Wedler, Robin Benedikt Rolnik, Hend Elrewany, Ehab Ghazy, Wolfgang Sippl, Martina Vetter, Markus (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12739169.txt.
Description
Nadine Bley and a large team studied why some ovarian cancers hide from the immune system in a 2025 paper. The C5 type of high grade serous cancer grows fast and keeps immune cells out. The team used single cell and bulk gene data to hunt for what drives that hidden state.
A screen pointed to proteins that bind RNA, with one named IGF2BP1 at the center. It speeds the loss of a protein that helps cells show their marks to immune cells. A small drug that blocks it worked with a PD-1 drug in mice to break the hidden state. Scans of human tumor tissue backed the same story.
Catalog record
| CREATOR | Nadine Bley, Alexander Rausch, Simon Müller, Theresa Simon, Markus Glaß, Danny Misiak, Laura Schian, Lara Meret Peters, Mohammad Dipto, Ali Hmedat, Bianca Busch, Annekatrin Schott, Marcell Lederer, Alice Wedler, Robin Benedikt Rolnik, Hend Elrewany, Ehab Ghazy, Wolfgang Sippl, Martina Vetter, Markus |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |